CS创新药全收益(H21152)
动态评分： 1.60分
业绩表现
| 总收益 | 年化收益 | 标准差 | 夏普比率 | 最大回撤 | 最大收益 | |
| 成立以来 | 147.1% | 8.8% | 8.86% | 39.45% | -62.77% | 295.29% |
| 过去1年 | 65.34% | 5.12% | -84.17% | -20.93% | 72.19% | |
| 过去2年 | 23.61% | 11.18% | 8.86% | 39.45% | -34.05% | 72.63% |
| 过去3年 | 17.97% | 5.66% | 8.86% | 39.45% | -43.18% | 72.63% |
| 过去5年 | -22.01% | -4.85% | 8.86% | 39.45% | -62.64% | 72.63% |
| 过去10年 | 92.62% | 6.78% | 8.86% | 39.45% | -62.77% | 241.04% |